Friday, April 24, 2015

08:30-09:20
Debate: Are SYSADOA effective for the treatment of osteoarthritis? 
Chairpersons
Jean-Pierre Pelletier, Canada
Juan José Scali, Argentina
 08:30
What are the evidences?
Roy D. Altman, USA
 08:50
Are other drug treatments better?
Jean-Pierre Raynauld, Canada
 09:10

Discussion


09:20-10:10
Lecture session: Today's treatment of osteoarthritis 
Chairpersons
Jordi Monfort, Spain
Hilde Berner Hammer, Norway
09:20
Guidelines for the treatment of osteoarthritis symptoms: How useful for the clinician?
Graeme Jones, Australia
09:40 Use of intraarticular therapy for the treatment of osteoarthritis
Emmanuel Maheu, France
10:00 Discussion

Saturday, April 25, 2015

08:30-09:20
Debate: Which imaging technologies may be of use in the diagnosis and/or management of osteoarthritis? 
Chairpersons
Roy D. Altman, USA
Jean-Pierre Pelletier, Canada
 
From the perspective of:
08:30
Radiologist: Charles G. Peterfy, USA  
08:40 Ultrasonographer: Hilde Berner Hammer, Norway
08:50 Functional Imaging: Jordi Monfort, Spain
09:00 Clinical Perspective: Graeme Jones, Australia
09:10

Discussion


09:20-10:10
Lecture session: Can osteoarthritis patients be better characterized by phenotyping?  
Chairpersons
Susanne Wang, USA
Charles G. Peterfy, USA
 09:20
Introduction: Is osteoarthritis an optimal disease for personalized medicine?
Daniel Lajeunesse, Canada

 09:25
Can genetics and epigenetics be used to phenotype osteoarthritis patients?
Hassan Fahmi, Canada 
 09:40
Use of MRI in the identification of different OA populations
Flavia Cicuttini, Australia 
 09:55

microRNAs as potential OA biomarkers differentiating early and late OA
Mohit Kapoor, Canada 


10:30-11:20
Lecture session: Today's and tomorrow's treatment of osteoarthritis: DMOADs 
Chairpersons
Johanne Martel-Pelletier, Canada
Olga Addimanda, Italy
10:30
DMOAD trials: What have we learnt from the last decade of experience?
Jean-Pierre Pelletier, Canada

10:50
The future of biological treatment of osteoarthritis
Susanne Wang, USA
11:10
Discussion

13:40-14:30
Lecture session: Muscle and fat: How are they related to osteoarthritis? 
Chairperson
Graeme Jones, Australia
13:40
Is sarcopenia associated with the genesis of knee osteoarthritis?
Michael Berger, Canada

14:00
Are exercise and weight loss helpful in reducing disease symptoms and progression?
Flavia Cicuttini, Australia
14:20
Discussion

14:30-15:20
Lecture session: Muscle and fat: How are they related to osteoarthritis? (cont'd) 
Chairperson
Jean-Pierre Raynauld, Canada
14:30
Are muscle area, muscle fat and adipokines risk factors for knee osteoarthritis?
Johanne Martel-Pelletier, Canada

14:50
Can adipokines be considered as drug targets in osteoarthritis?
Juan Jose Scali, Argentina
15:10
Discussion

15:40-16:30
Joint OA/RA Session: Cardiovascular outcomes in OA and RA  
Chairpersons
Jean-Pierre Raynauld, Canada
Jean-Pierre Pelletier, Canada
15:40
Cardiovascular risk factors associated with osteoarthritis
Guy Leclerc, Canada

16:00
Cardiovascular effect of commonly used medications in the management of RA
Boulos Haraoui, Canada
16:20
Discussion

 17:00-18:00
Round Table: Erosive hand osteoarthritis: What have we learned since the beginning of the 21st century?
Radiological, clinical, ultrasonographic and MRI viewpoints 
 Chairperson
Emmanuel Maheu, France
  Speakers:
17:00
Erosive hand OA: Clinico-radiological update
Emmanuel Maheu, France
17:15
Erosive hand OA: What have we learned from ultrasonography? 
Olga Addimanda
, Italy
17:30
Erosive hand OA: What have we learned from MRI? 
Ida K. Haugen
, Norway
17:45
Discussion